Royal Prima Tbk. (PRIM)
PT Royal Prima Tbk
Rp 82
-1,00(-1,20%)
POSTPOST- Harga Pasar: Rp 82
- Volume Perdagangan: Rp 8.769.600
- Kapitalisasi Pasar: Rp 277.022.244.864
- Mata Uang: IDR
- Pasar: id_market
- Dividend Yield: -%
- Dividend Rate: Rp -
- Price to Book: 0,29
- Forward P/E: -
- Trailing P/E: -
- EPS Tahun Ini: Rp -2,11
- EPS Perkiraan: Rp -
- Bid: Rp 81,00
- Ask: Rp 82,00
- Bid Size: 0,00
- Ask Size: 0,00
- Volume Rata-rata 10 Hari: 20.812.460
- Volume Rata-rata 3 Bulan: 21.874.314
- Book Value: Rp 282,57
- Fifty Day Average: Rp 82,68
- Two Hundred Day Average: Rp 70,36
- 52 Week Range: 50.0 - 116.0
- 52 Week High: Rp 116,00
- 52 Week Low: Rp 50,00
- Regular Market Open: Rp 84,00
- Regular Market Previous Close: Rp 83,00
- Regular Market Day High: Rp 84,00
- Regular Market Day Low: Rp 81,00
- Earnings Call Start: -
- Earnings Call End: -
- Earnings Timestamp: -
Sektor
Healthcare
Industri
Medical Care Facilities
Alamat Perusahaan
Gedung Grand Slipi Tower
Jl. Letjen S. Parman Kav. 22-24
Jakarta
11480
Ringkasan Bisnis
PT Royal Prima Tbk engages in providing hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, maternity, paediatric care, endoscopy, endoscopy, cath lab, stroke centre, and trauma centre. The company's other services include acupuncture, anaesthesia, beauty and wellness, dermatology, dental and mouth, endocrine, digestive, vascular, neurology, ENT, haematology, nephrology, nutrient, consultancy, oncology, plastic and paediatric surgery, neurosurgery, obgyn and fertilization, ophthalmology, chemotherapy, psychiatrist, psychology, pulmonology, orthopaedic, and paediatric orthopaedic. The company was founded in 2013 and is based in Jakarta, Indonesia.
Ebook ProfitWise - Metode FCDS-T mencari Saham MultiBagger(Terjual ke 2000+ Investor)
Metode FCDS-T: Strategi investasi dengan CAGR >35% yang membantu modal Rp100 juta berkembang menjadi Rp1,1 miliar dalam 8 tahun.
Cocok untuk investor yang ingin:
- Memiliki sinyal jual/beli jelas
- Aturan investasi objektif (tanpa emosi)
- Menghemat waktu (hanya 4x analisis/tahun)
- Mencapai tujuan finansial
Bonus: Template spreadsheet + Konsultasi gratis!